From the Journals

Performance matters in adenoma detection


 

FROM CLINICAL GASTROENTEROLOGY & HEPATOLOGY

Improve performance, but don’t discount patient factors

The study is important at this time because colorectal cancer is the third-leading cause of cancer death in the United States, Atsushi Sakuraba, MD, of the University of Chicago said in an interview.

“Screening colonoscopy has been shown to decrease CRC mortality, but factors influencing outcomes after screening colonoscopies remain to be determined,” he said.

“It was expected that high-quality colonoscopy performed by an endoscopist with ADR of 25% or greater was associated with a lower risk for CRC death,” Dr. Sakuraba said. “The strength of the study is that the authors demonstrated that high-quality colonoscopy was more important in individuals with high-risk adenomas, such as advanced adenomas or at least three adenomas.”

The study findings have implications for practice in that they show the importance of monitoring performance quality in screening colonoscopy, Dr. Sakuraba said, “especially when patients have high-risk adenomas.” However, “the authors included only age and sex as variables, but the influence of other factors, such as smoking, [body mass index], and race, need to be studied.”

The researchers had no financial conflicts to disclose. Dr. Sakuraba had no financial conflicts to disclose.

Pages

Recommended Reading

Hypothesis: Milk and beef ‘causally linked’ to colorectal cancer
MDedge Hematology and Oncology
Is it time for universal genetic testing in colorectal cancer?
MDedge Hematology and Oncology
Hyperprogression on immunotherapy: When outcomes are much worse
MDedge Hematology and Oncology
FDA okays upfront pembro for advanced HER2+ gastric cancer
MDedge Hematology and Oncology
Does surgery for colorectal liver metastases release tumor cells?
MDedge Hematology and Oncology
USPSTF final recommendation on CRC screening: 45 is the new 50
MDedge Hematology and Oncology
Pandemic colonoscopy restrictions may lead to worse CRC outcomes
MDedge Hematology and Oncology
CRC screening guidelines: 45 is the new 50, and 85 is the new 75
MDedge Hematology and Oncology
NPs and PAs performing colonoscopies: Why not?
MDedge Hematology and Oncology
Third COVID-19 vaccine dose helped some transplant recipients
MDedge Hematology and Oncology